S110 preclinical data presented by Dr. Peter Jones, Director of USC's Norris Cancer Center SAN FRANCISCO, Oct. 25 /PRNewswire-FirstCall/ -- SuperGen Inc. (NASDAQ:SUPG), a pharmaceutical company dedicated to the discovery, rapid development and commercialization of therapies for solid tumors and hema http://service.meltwaternews.com/mnews/redirect.html?docId=319159379&userId=683154&cId=197010&agentId=103736&type=2&s=25007&url=http%3A%2F%2Fc.moreover.com%2Fclick%2Fhere.pl%3Fz1152225953%26z%3D950241192
